As scientists search for new drug targets and screen for compounds to treat disease, they often run into roadblocks related to data quality. Researchers must use their expertise to circumvent these problems if they hope to rapidly develop high-quality, novel therapeutics. In this webinar sponsored by Thermo Fisher Scientific, Drew Adams will discuss his work identifying new targets and screening small molecules to develop therapeutics for neurological diseases, with an emphasis on resolving data quality problems.
Topics to be covered
Data quality in high-throughput screening and target validation
Validating new targets and small molecules targeting cholesterol biosynthesis to promote remyelination
Thursday, October 28, 2021
2:30 - 3:30 PM Eastern Time
Meet the speaker
Drew Adams, PhD Thomas F. Peterson Professor of Novel Therapeutics Associate Professor, Genetics and Genome Sciences Director, Small Molecule Drug Development Core Case Western Reserve University School of Medicine
Sponsored by
Register
TS_Webinar_Thermo Fisher_LabTools_High-Quality Screening and Target Validation During Drug Development October 28, 2021
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
